Drug intelligence / Profile preview

HP-802-247

Development stage
Phase 3
Lead developer
Smith & Nephew
Modality
Cell Therapies, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Topical
01

Overview

HP-802-247 is a cell-based combination product designed for the treatment of chronic wounds, particularly venous leg ulcers. It consists of a fibrinogen solution and a cell preparation containing allogeneic, non-proliferating, living human keratinocytes and fibroblasts delivered in a fibrin matrix by spray application. The mechanism of action involves the release of various growth and angiogenic factors from these metabolically active cells into the wound microenvironment, which stimulates the patient’s own cells to promote healing. Developed as an advanced tissue engineering therapy, it was evaluated in multiple clinical trials for efficacy and safety in chronic venous leg ulcers. The developer/manufacturer is Healthpoint Biotherapeutics.

Other names
topical wound spray HP802-247

Beyond the preview

Go deeper on HP-802-247.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HP-802-247.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call